Laman UtamaAIMI • OTCMKTS
add
AIM ImmunoTech Inc
Tutup sebelumnya
$0.068
Julat hari
$0.051 - $0.087
Julat tahun
$0.025 - $0.36
Permodalan pasaran
4.93J USD
Bilangan Purata
408.61K
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
OTCMKTS
Berita pasaran
.INX
0.00%
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(USD) | Dis 2024info | Perubahan T/T |
---|---|---|
Hasil | 45.00K | -30.77% |
Perbelanjaan pengendalian | 5.89J | -58.08% |
Pendapatan bersih | -5.97J | 52.55% |
Margin untung bersih | -13.26K | 31.46% |
Pendapatan bagi setiap syer | -0.10 | 64.56% |
EBITDA | -5.79J | 58.48% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
(USD) | Dis 2024info | Perubahan T/T |
---|---|---|
Pelaburan tunai dan jangka pendek | 3.98J | -69.57% |
Jumlah aset | 8.61J | -55.59% |
Jumlah liabiliti | 9.93J | 8.56% |
Jumlah ekuiti | -1.32J | — |
Syer tertunggak | 72.29J | — |
Harga kepada buku | -3.40 | — |
Pulangan pada aset | -131.89% | — |
Pulangan pada modal | -369.07% | — |
Aliran Tunai
Perubahan bersih dalam tunai
(USD) | Dis 2024info | Perubahan T/T |
---|---|---|
Pendapatan bersih | -5.97J | 52.55% |
Tunai daripada operasi | -3.96J | 59.47% |
Tunai daripada pelaburan | 3.70J | 1,830.84% |
Tunai daripada pembiayaan | 1.04J | 605.44% |
Perubahan bersih dalam tunai | 786.00K | 108.00% |
Aliran tunai bebas | -3.65J | 40.05% |
Perihal
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees.
The company has created an immunomodulatory double stranded RNA drug called Ampligen.
It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome. Wikipedia
Diasaskan
1966
Ibu pejabat
Tapak web
Pekerja
22